scholarly journals Lgr5 positive stem cells sorted from small intestines of diabetic mice differentiate into higher proportion of absorptive cells and Paneth cellsin vitro

2015 ◽  
Vol 57 (6) ◽  
pp. 453-465 ◽  
Author(s):  
Xian-Yang Zhong ◽  
Tao Yu ◽  
Wa Zhong ◽  
Jie-Yao Li ◽  
Zhong-Sheng Xia ◽  
...  
Keyword(s):  
Stem Cells ◽  
Diabetic Mice ◽  
Absorptive Cells ◽  
Small Intestines

scholarly journals Insulin-secreting cells derived from embryonic stem cells normalize glycemia in streptozotocin-induced diabetic mice

Diabetes ◽  
2000 ◽  
Vol 49 (2) ◽  
pp. 157-162 ◽  
Author(s):  
B. Soria ◽  
E. Roche ◽  
G. Berna ◽  
T. Leon-Quinto ◽  
J. A. Reig ◽  
...  
Keyword(s):  
Stem Cells ◽  
Embryonic Stem Cells ◽  
Embryonic Stem ◽  
Diabetic Mice ◽  
Insulin Secreting Cells

scholarly journals The tissue origin of human mesenchymal stem cells dictates their therapeutic efficacy on glucose and lipid metabolic disorders in type II diabetic mice

2021 ◽  
Vol 12 (1) ◽  
Author(s):  
Yinzhong Ma ◽  
Lisha Wang ◽  
Shilun Yang ◽  
Dongyu Liu ◽  
Yi Zeng ◽  
...  
Keyword(s):  
Stem Cells ◽  
Mesenchymal Stem Cells ◽  
Therapeutic Efficacy ◽  
Metabolic Disorders ◽  
Human Mscs ◽  
Dependent Manner ◽  
Type Ii ◽  
Diabetic Mice ◽  
Histological Lesion ◽  
Insulin Levels

Abstract Background The therapeutic efficacy of mesenchymal stem cells (MSCs) of different tissue origins on metabolic disorders can be varied in many ways but remains poorly defined. Here we report a comprehensive comparison of human MSCs derived from umbilical cord Wharton’s jelly (UC-MSCs), dental pulp (PU-MSCs), and adipose tissue (AD-MSCs) on the treatment of glucose and lipid metabolic disorders in type II diabetic mice. Methods Fourteen-to-fifteen-week-old male C57BL/6 db/db mice were intravenously administered with human UC-MSCs, PU-MSCs, and AD-MSCs at various doses or vehicle control once every 2 weeks for 6 weeks. Metformin (MET) was given orally to animals in a separate group once a day at weeks 4 to 6 as a positive control. Body weight, blood glucose, and insulin levels were measured every week. Glucose tolerance tests (GTT) and insulin tolerance tests (ITT) were performed every 2 weeks. All the animals were sacrificed at week 6 and the blood and liver tissues were collected for biochemical and histological examinations. Results UC-MSCs showed the strongest efficacy in reducing fasting glucose levels, increasing fasting insulin levels, and improving GTT and ITT in a dose-dependent manner, whereas PU-MSCs showed an intermediate efficacy and AD-MSCs showed the least efficacy on these parameters. Moreover, UC-MSCs also reduced the serum low-density lipoprotein cholesterol (LDL-C) levels with the most prominent potency and AD-MSCs had only very weak effect on LDL-C. In contrast, AD-MSCs substantially reduced the lipid content and histological lesion of liver and accompanying biomarkers of liver injury such as serum aspartate transaminase (AST) and alanine aminotransferase (ALT) levels, whereas UC-MSCs and PU-MSCs displayed no or modest effects on these parameters, respectively. Conclusions Taken together, our results demonstrated that MSCs of different tissue origins can confer substantially different therapeutic efficacy in ameliorating glucose and lipid metabolic disorders in type II diabetes. MSCs with different therapeutic characteristics could be selected according to the purpose of the treatment in the future clinical practice.

scholarly journals Role of the autologous mesenchymal stem cells compared with platelet rich plasma on cicatrization of cutaneous wounds in diabetic mice

2016 ◽  
Vol 36 (7) ◽  
pp. 617-624
Author(s):  
Napoleão M. Argolo Neto ◽  
Ricardo J. Del Carlo ◽  
Betânia S. Monteiro ◽  
Nance B. Nardi ◽  
Pedro C. Chagastelles ◽  
...  
Keyword(s):  
Stem Cells ◽  
Mesenchymal Stem Cells ◽  
Platelet Rich Plasma ◽  
Cutaneous Lesion ◽  
Healing Time ◽  
Diabetic Mice ◽  
Cutaneous Lesions ◽  
Cutaneous Wounds ◽  
Autologous Mesenchymal Stem Cells ◽  
Treatment Of Wounds

Abstract: Chronic cutaneous lesions affect 15% of diabetic human patients and represent a risk 15 to 46 times larger of limb amputations compared to people with normal glycemia. It is assumed that half of these amputations could be prevented by early treatment of wounds, for example, with proper cell therapy. Objectives: In this study, the action of the autologous transplant of mesenchymal stem-cells (MSC) was evaluated compared to the treatment with autologous platelet rich plasma (PRP) in the cicatrization of cutaneous lesions induced in diabetic mice. These animals were previously treated with streptozootocin to induce diabetes mellitus and round wounds of 1.5cm in diameter were created in the posterior region. Diameters of the wounds and healing time were evaluated during 30 days and the results were submitted to variance analysis and Tukey's test average. It was noticed that the animals treated with MSC presented a more accelerated cicatrization of the cutaneous lesion than the animals treated with PRP. However, the treatment with PRP presented better results than just the daily asepsis of the lesions with saline or covering them with semi-permeable bandage. Besides, the use of semi-permeable bandage kept the cutaneous lesions of diabetic mice did not interfere negatively with cicatrization, proved to be harmless to use, but kept the cutaneous lesions more hydrated than the ones exposed to the environment.

Potential of adipose-derived stem cells harvested from diabetic mice on wound healing

2009 ◽  
Vol 209 (3) ◽  
pp. S89
Author(s):  
Pouya Dastouri ◽  
Rei Ogawa ◽  
Douglas Helm ◽  
Paolo Erba ◽  
Dennis P. Orgill
Keyword(s):  
Stem Cells ◽  
Wound Healing ◽  
Adipose Derived Stem Cells ◽  
Diabetic Mice

scholarly journals 928 Combination bioengineered wound scaffolds containing timolol-preconditioned mesenchymal stem cells promote wound healing in diabetic mice

2017 ◽  
Vol 137 (5) ◽  
pp. S160
Author(s):  
H. Yang ◽  
M. So ◽  
F. Fierro ◽  
H. Stewart ◽  
A. Vu Nguyen ◽  
...  
Keyword(s):  
Stem Cells ◽  
Wound Healing ◽  
Mesenchymal Stem Cells ◽  
Diabetic Mice ◽  
Promote Wound Healing

The reversal of hyperglycaemia in diabetic mice using PLGA scaffolds seeded with islet-like cells derived from human embryonic stem cells

Biomaterials ◽  
2009 ◽  
Vol 30 (9) ◽  
pp. 1706-1714 ◽  
Author(s):  
Gen-hong Mao ◽  
Gui-an Chen ◽  
Hai-yan Bai ◽  
Tian-ran Song ◽  
Yan-xia Wang
Keyword(s):  
Stem Cells ◽  
Embryonic Stem Cells ◽  
Human Embryonic Stem Cells ◽  
Embryonic Stem ◽  
Diabetic Mice

scholarly journals Adipose stem cells isolated from diabetic mice improve cutaneous wound healing in streptozotocin-induced diabetic mice

2020 ◽  
Vol 11 (1) ◽  
Author(s):  
Ran An ◽  
Yong Zhang ◽  
Yu Qiao ◽  
Lili Song ◽  
Hongjun Wang ◽  
...  
Keyword(s):  
Stem Cells ◽  
Wound Healing ◽  
Adipose Stem Cells ◽  
Cutaneous Wound Healing ◽  
Diabetic Mice ◽  
Cutaneous Wound

Bone marrow mesenchymal stem cells promote the repair of islets from diabetic mice through paracrine actions

2014 ◽  
Vol 388 (1-2) ◽  
pp. 41-50 ◽  
Author(s):  
Xiaodong Gao ◽  
Lujun Song ◽  
Kuntang Shen ◽  
Hongshan Wang ◽  
Mengjia Qian ◽  
...  
Keyword(s):  
Stem Cells ◽  
Bone Marrow ◽  
Mesenchymal Stem Cells ◽  
Diabetic Mice ◽  
Marrow Mesenchymal Stem Cells ◽  
Paracrine Actions

scholarly journals Co-transplantation of Human Fetal Mesenchymal and Hematopoietic Stem Cells in Type 1 Diabetic Mice Model

2019 ◽  
Vol 10 ◽  
Author(s):  
Babak Arjmand ◽  
Parisa Goodarzi ◽  
Hamid Reza Aghayan ◽  
Moloud Payab ◽  
Fakher Rahim ◽  
...  
Keyword(s):  
Stem Cells ◽  
Hematopoietic Stem Cells ◽  
Diabetic Mice ◽  
Mice Model ◽  
Hematopoietic Stem
Sign in / Sign up

Export Citation Format

Share Document